• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Screening Colonoscopy Can Reduce Mortality, Study Finds


The retrospective study, conducted in centers across Germany, found that when colorectal cancer was detected during a screening colonoscopy, patients lived nearly 2 years longer than if it was detected during a diagnostic colonoscopy.

A long-term, retrospective, multicenter study in Germany followed 60 patients diagnosed with colorectal cancer (CRC) during screening colonoscopy and 252 patients during diagnostic colonoscopy in 2002, 2003, and 2004. The patients, 55 years of age or older, were followed for about a decade till 2013, with survival as the primary outcome being analyzed.

The study, published in Gastrointestinal Endoscopy, found that patients with CRC diagnosed during screening colonoscopy lived significantly longer (20.2 months longer) when compared with patients with CRC diagnosed during diagnostic colonoscopy. About 55% of the patients with diagnostic colonoscopy, and about 77% of the screening colonoscopy patients, survived beyond the time period of the study.

Read more on ScienceDaily

Related Videos
Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology
Video 7 - "Future Opportunities in Genitourinary Cancers"
Video 6 - "LITESPARK-003 Trial Insights: Updates from ESMO 2023"
Video 5 - "Key Highlights from EV-302 Study at ESMO 2023"
Siamak Daneshmand, MD, discusses the results of SunRISe-1 study of TAR-200, an intravesical drug delivery system, in patients with BCG-unresponsive HR NMIBC from ESMO 2023.
Dr Jennifer Brown
Video 4 - "Assessing Efficacy of Treatment Through Patient-Reported Outcomes"
Related Content
© 2023 MJH Life Sciences
All rights reserved.